TY  - JOUR
AU  - Sijbrandij, M
AU  - Farooq, S
AU  - Bryant, RA
AU  - Dawson, K
AU  - Hamdani, SU
AU  - Chiumento, A
AU  - Minhas, F
AU  - Saeed, K
AU  - Rahman, A
AU  - van Ommeren, M
Y2  - 2021/02/04
Y1  - 2015/10/01
SN  - 1471-244X
UR  - http://hdl.handle.net/11343/259167
AB  - BACKGROUND: In humanitarian settings common mental disorders (depression, anxiety disorders, posttraumatic stress disorder) are highly prevalent. The World Health Organization (WHO) has developed Problem Management Plus (PM+), a 5-session, individual psychological intervention program, delivered by paraprofessionals that addresses common mental disorders in people in communities affected by adversity. The objectives of this study are to test effectiveness and cost-effectiveness of the locally adapted PM+ compared to Treatment as usual (TAU) in Peshawar District, Pakistan. METHODS: A randomised controlled trial will be conducted in 346 primary care attendees in 3 health care centres in Peshawar District, Pakistan. After informed consent, primary care attendees with high levels of psychological distress according to the General Health Questionnaire-12 (GHQ-12) and functional impairment (WHO Disability Assessment Schedule 2.0 (WHODAS)) will be assigned to PM+ (n = 173) or TAU (n = 173). At baseline, 1 week and 3 months following PM+, independent assessors will assess psychological distress with the Hospital Anxiety and Depression Scale (HADS), and functional disability with the WHODAS. Secondary outcomes are posttraumatic stress disorder (PTSD) symptoms, and client-perceived priority problems. Further, cost-effectiveness will be assessed using the Service Receipt Inventory (SRI). DISCUSSION: If proven effective, PM+ will be rolled out to other areas for further adaptation and testing in diverse humanitarian settings. TRIAL REGISTRATION: ACTRN12614001235695. Registered 26 November 2014. Australian New Zealand Clinical Trials Registry.
LA  - English
PB  - BMC
T1  - Problem Management Plus (PM plus ) for common mental disorders in a humanitarian setting in Pakistan; study protocol for a randomised controlled trial (RCT)
DO  - 10.1186/s12888-015-0602-y
IS  - BMC Psychiatry
VL  - 15
IS  - 1
L1  - /bitstream/handle/11343/259167/PMC4591562.pdf?sequence=1&isAllowed=y
ER  -